Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anca, M. H.
Right arrow Articles by Korczyn, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anca, M. H.
Right arrow Articles by Korczyn, A. D.
Related Collections
Right arrow Tourette syndrome
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)
NEUROLOGY 2004;62:1626-1627
© 2004 American Academy of Neurology


Brief Communications

Ropinirole in Gilles de la Tourette syndrome

Marietta H. Anca, MD, Nir Giladi, MD and Amos D. Korczyn, MD

From the Department of Neurology, Tel-Aviv Medical Center, and the Sieratzki Chair of Neurology, Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Address correspondence and reprint requests to Dr. A.D. Korczyn, Department of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv 69978, Israel; e-mail: neuro13{at}post.tau.ac.il

The effects of treatment with ropinirole (0.25 to 0.5 mg bid) were examined using an open-label design for 8 weeks in 15 subjects with Gilles de la Tourette syndrome (GdlT). All patients completed the study, and most showed an improvement in their tics during treatment. Low-dose ropinirole may improve the motor features in GdlT, but further controlled studies are necessary.


Received April 2, 2002. Accepted in final form December 30, 2003.




This article has been cited by other articles:


Home page
J Child NeurolHome page
D. Gilbert
Treatment of Children and Adolescents With Tics and Tourette Syndrome
J Child Neurol, August 1, 2006; 21(8): 690 - 700.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
D. L. Gilbert and C. R. Buncher
Assessment of Scientific and Ethical Issues in Two Randomized Clinical Trial Designs for Patients With Tourette's Syndrome: A Model for Studies of Multiple Neuropsychiatric Diagnoses
J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 324 - 332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.